Assessing and Improving Value in Cancer Care Workshop Summary (2009) / Chapter Skim
Currently Skimming:
Appendix B: Speaker and Moderator Biographies
Appendix B: Speaker and Moderator Biographies
Pages 129-148
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 129... ...
He has published widely on patterns of care, costs, and cost-effectiveness of treatments for lung, colorectal, and prostate cancer. His current studies -- funded by the National Cancer Institute, National Human Genome Research Institute, Centers for Disease Control and Prevention, and several pharmaceutical manufacturers -- include projects to develop a genetic screening policy model for colorectal cancer, a multicenter study of decision making for men with newly diagnosed prostate cancer, and studies of cancer screening, incidence, treatment, and outcomes for Native Americans diagnosed with cancer.
|
From page 130... ...
Anthony Back, M.D., is Professor of Medicine at the University of Washington in Seattle. He is Director of the Cancer Communication and Palliative Care Programs at the Seattle Cancer Care Alliance and the Fred Hutchinson Cancer Research Center.
|
From page 131... ...
Ms. Blum's awards include the Lifetime Achievement Award from the Board of Sponsors of National Breast Cancer Awareness Month, the Special Recognition Award from the National Coalition for Cancer Survivorship, the Republic Bank Breast Cancer Research Foundation Award, and the Special Recognition Award of the American Society of Clinical Oncology.
|
From page 132... ...
He served as Staff Philosopher on the President's Commission for the Study of Ethical Problems in Medicine in 1981–1982, and in 1993 was a member of the Ethics Working Group of the Clinton Task Force on National Health Reform. He has been a consultant in biomedical ethics and health policy to numerous national and international bodies, including the Office of Technology Assessment of the U.S.
|
From page 133... ...
One major area of his research focuses on assessing the impact of managed care on the health care marketplace, with an emphasis on examining the impact of managed care on health care cost growth and on the use of medical technology. Other research has examined determinants of patient choice of hospital and the impact of health plan performance measures on employee and employer selection of health plans.
|
From page 134... ...
She is also a Research Associate of the National Bureau of Economic Research. Board memberships include the Board of the International Health Economics Association.
|
From page 135... ...
His particular field of interest is in the economic evaluation of health care treatments and programs. He has undertaken evaluations in a wide range of medical fields including care of the elderly, neonatal intensive care, immunization programs, services for people with AIDS, eye health care, and pharmaceuticals.
|
From page 136... ...
He served as member of the California Breast Cancer Research Council from 1996 to 1999 and was its Chairman from 1997 to 1999.
|
From page 137... ...
under the Agency for Healthcare Research and Quality (AHRQ) , and Coordinator of the Technical Expert Panel of the National Guideline Clearinghouse (a project sponsored by AHRQ in cooperation with the American Medical Association and the American Association of Health Plans)
|
From page 138... ...
A graduate of T rinity College, Emory University, and Catholic University, Mary McCabe held several positions at the National Cancer Institute before joining the Memorial Sloan-Kettering Cancer Center, including Assistant Director of the Division of Cancer Treatment and Diagnosis, Director of the Office of Clinical Research Promotion, and faculty member of the Department of Bioethics at the National Institutes of Health (NIH)
|
From page 139... ...
He has served as president of the American Association for Cancer Research, chair of the NIH Chemical Pathology Study Section, is a member of the Integration Panel for the U.S. Army Breast Cancer Program, is Co-Chair of the Breast Cancer Progress Review Group for the National Cancer Institute and Chair of the National Cancer Institute Cancer Centers review panel.
|
From page 140... ...
Dr. Newcomer is a board-certified medical oncologist; he practiced medical oncology for 9 years in Tulsa, Oklahoma, and Minneapolis (Park Nicollet Clinic)
|
From page 141... ...
From 1996 to 2005 he was involved in the development and registration of a number of oncology supportive care therapies including responsibility for the design and conduct of a number of phase II, P3, and postlicensing clinical trials. In these clinical development roles he was responsible for directly interacting with the EMEA, the FDA, and other regulatory agencies.
|
From page 142... ...
. He has authored over 150 peer-reviewed manuscripts, book chapters, editorials, and letters, including first-author publications in the New England Journal of Medicine, Journal of the National Cancer Institute, Journal of Clinical Oncology, Cancer, Controlled Clinical Trials, Biometrics, Statistics in Medicine, and Seminars in Oncology.
|
From page 143... ...
Thomas J Smith, M.D., is the Massey Endowed Professor of Palliative Care Research and Esteemed Professor of Medicine at the Virginia Commonwealth University -- Massey Cancer Center in Richmond.
|
From page 144... ...
In 2008 the VCU's Rural Cancer Outreach Program won the Hematology/ Oncology News International HOPE award for leadership in small clinical programs and the HOPE award for clinical excellence for integration of palliative care into regular cancer care.
|
From page 145... ...
Stovall is frequently called upon to work with administration and congressional staff on a variety of cancer-related policy issues, most notably access to quality cancer care. Sean Tunis, M.D., M.Sc., is the Founder and Director of the Center for Medical Technology Policy in San Francisco, where he works with health care decision makers, experts, and stakeholders to improve the value of clinical research on new and existing medical technologies.
|
From page 146... ...
Ubel, M.D., is Professor of Medicine and Professor of Psychology at the University of Michigan, a primary care physician at the Ann Arbor Veterans Affairs Medical Center, Associate Director of the Michigan Robert Wood Johnson Clinical Scholars Program, and Director of the Center for Behavioral and Decision Sciences in Medicine at the University of Michigan. His research explores controversial issues about the role of values and preferences in health care decision making, from decisions at the bedside to policy decisions.
|
From page 147... ...
Janet Woodcock, M.D., is the Director of the Center for Drug Evaluation and Research. She previously held various positions within the Office of the Commissioner, FDA, as Deputy Commissioner and Chief Medical Officer, she shared responsibility and collaborated with the Commissioner in planning, organizing, directing, staffing, coordinating, controlling, and evaluating the agency's scientific and medical regulatory activities in order to achieve the mission of FDA.
|
From page 148... ...
, the Leadership Award in Personalized Medicine from the Personalized Medicine Coalition, three HHS Secretary's Distinguished Service Awards, and the HHS Asian-Pacific Network achievement award (2001)
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.